Anti-BCMA/FcRL5 CAR-T cell therapy

CAR-T cell therapy targeting BCMA and FcRL5 · Xuzhou Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-BCMA/FcRL5 CAR-T cell therapy, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM) [Phase 1, Phase 2]

See pricing